Cargando…

Plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure

OBJECTIVE: To define which oxidative stress markers could be used as diagnostic tools in the assessment of post-infarction heart failure (HF). METHODS: This observational study enrolled patients with HF that were divided into three subgroups (ejection fraction [EF] ≥ 50%; EF 40–49%; EF < 40%) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Cvetkovic, Tatjana, Saric, Sandra, Stefanovic, Nikola, Stojiljkovic, Vladana, Djordjevic, Branka, Stojanovic, Dijana, Cvetkovic, Mina, Deljanin Ilic, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793051/
https://www.ncbi.nlm.nih.gov/pubmed/36564997
http://dx.doi.org/10.1177/03000605221139711
_version_ 1784859771492368384
author Cvetkovic, Tatjana
Saric, Sandra
Stefanovic, Nikola
Stojiljkovic, Vladana
Djordjevic, Branka
Stojanovic, Dijana
Cvetkovic, Mina
Deljanin Ilic, Marina
author_facet Cvetkovic, Tatjana
Saric, Sandra
Stefanovic, Nikola
Stojiljkovic, Vladana
Djordjevic, Branka
Stojanovic, Dijana
Cvetkovic, Mina
Deljanin Ilic, Marina
author_sort Cvetkovic, Tatjana
collection PubMed
description OBJECTIVE: To define which oxidative stress markers could be used as diagnostic tools in the assessment of post-infarction heart failure (HF). METHODS: This observational study enrolled patients with HF that were divided into three subgroups (ejection fraction [EF] ≥ 50%; EF 40–49%; EF < 40%) and age- and sex-matched healthy control subjects. The plasma concentrations of advanced oxidation protein products (AOPP), thiobarbituric acid reactive substances, catalase activity and free thiols were determined in all participants. RESULTS: The study enrolled 81 patients with HF and 68 healthy control subjects. There were significant differences in the values ​​of oxidative stress markers between patients and controls. Oxidative stress parameters did not differ between the subgroups of patients, except for AOPP, which was significantly higher in the EF < 40% group. Univariate and multivariate logistic regression analyses showed an association between AOPP and HF in the EF ≥ 50% group, while receiver operating characteristic (ROC) curve analysis identified a cut-off value of 60.89 µmol/l for AOPP. CONCLUSIONS: Based on the ROC curve analysis of AOPP and the higher significance in the multivariate analyses for patients with EF ≥ 50%, these current results suggest that AOPP could be a useful additional tool in the assessment of post-infarction HF.
format Online
Article
Text
id pubmed-9793051
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-97930512022-12-28 Plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure Cvetkovic, Tatjana Saric, Sandra Stefanovic, Nikola Stojiljkovic, Vladana Djordjevic, Branka Stojanovic, Dijana Cvetkovic, Mina Deljanin Ilic, Marina J Int Med Res Retrospective Clinical Research Report OBJECTIVE: To define which oxidative stress markers could be used as diagnostic tools in the assessment of post-infarction heart failure (HF). METHODS: This observational study enrolled patients with HF that were divided into three subgroups (ejection fraction [EF] ≥ 50%; EF 40–49%; EF < 40%) and age- and sex-matched healthy control subjects. The plasma concentrations of advanced oxidation protein products (AOPP), thiobarbituric acid reactive substances, catalase activity and free thiols were determined in all participants. RESULTS: The study enrolled 81 patients with HF and 68 healthy control subjects. There were significant differences in the values ​​of oxidative stress markers between patients and controls. Oxidative stress parameters did not differ between the subgroups of patients, except for AOPP, which was significantly higher in the EF < 40% group. Univariate and multivariate logistic regression analyses showed an association between AOPP and HF in the EF ≥ 50% group, while receiver operating characteristic (ROC) curve analysis identified a cut-off value of 60.89 µmol/l for AOPP. CONCLUSIONS: Based on the ROC curve analysis of AOPP and the higher significance in the multivariate analyses for patients with EF ≥ 50%, these current results suggest that AOPP could be a useful additional tool in the assessment of post-infarction HF. SAGE Publications 2022-12-23 /pmc/articles/PMC9793051/ /pubmed/36564997 http://dx.doi.org/10.1177/03000605221139711 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Retrospective Clinical Research Report
Cvetkovic, Tatjana
Saric, Sandra
Stefanovic, Nikola
Stojiljkovic, Vladana
Djordjevic, Branka
Stojanovic, Dijana
Cvetkovic, Mina
Deljanin Ilic, Marina
Plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure
title Plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure
title_full Plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure
title_fullStr Plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure
title_full_unstemmed Plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure
title_short Plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure
title_sort plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure
topic Retrospective Clinical Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793051/
https://www.ncbi.nlm.nih.gov/pubmed/36564997
http://dx.doi.org/10.1177/03000605221139711
work_keys_str_mv AT cvetkovictatjana plasmaadvancedoxidationproductsasanadditionaltoolinassessmentofpostinfarctionheartfailure
AT saricsandra plasmaadvancedoxidationproductsasanadditionaltoolinassessmentofpostinfarctionheartfailure
AT stefanovicnikola plasmaadvancedoxidationproductsasanadditionaltoolinassessmentofpostinfarctionheartfailure
AT stojiljkovicvladana plasmaadvancedoxidationproductsasanadditionaltoolinassessmentofpostinfarctionheartfailure
AT djordjevicbranka plasmaadvancedoxidationproductsasanadditionaltoolinassessmentofpostinfarctionheartfailure
AT stojanovicdijana plasmaadvancedoxidationproductsasanadditionaltoolinassessmentofpostinfarctionheartfailure
AT cvetkovicmina plasmaadvancedoxidationproductsasanadditionaltoolinassessmentofpostinfarctionheartfailure
AT deljaninilicmarina plasmaadvancedoxidationproductsasanadditionaltoolinassessmentofpostinfarctionheartfailure